4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001218629-26-000002
Bd. Co-Chair, President & CEO gave up 28,570 shares (to pay taxes)
- Bd. Co-Chair, President & CEO acquired 28,570 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SCHLEIFER LEONARD S · Bd. Co-Chair, President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 1 in the form | +28,570 | 243,093 | D | ||
| 2025-12-31 | Shares withheld for taxes : show line 2 in the form | −28,570 | $772.09 | $22,058,611 | 214,523 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-31 | Exercise or conversion : show line 3 in the form 2020 Performance Stock Units | −28,570 | 595,077 | D |
Loading xslF345X05/edgardoc.xml…